Robeco Institutional Asset Management B.V.
Position in MRK — Merck & Co., Inc.
CIK 1418773
ROTTERDAM, P7
Position in MRK
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$305,058,100
+$25,709,476 QoQ
Shares Held
2,373,993
+2.2% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#98
of 3,757 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 28%
Shared 0%
None 72%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Robeco Institutional Asset Management B.V. holds $4,134,092,265 across 9 Drug Manufacturers - General names. MRK ranks #6 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
758,740 | $910,055,594 | |
| 2 | ABBV |
AbbVie Inc.
|
3,565,119 | $897,126,545 | |
| 3 | JNJ |
Johnson & Johnson
|
1,966,109 | $499,332,702 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
3,459,893 | $437,122,881 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
7,244,630 | $417,435,580 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
2,373,993 | $305,058,100 | |
| 7 | PFE |
Pfizer Inc
|
11,918,197 | $286,990,183 | |
| 8 | AMGN |
Amgen Inc
|
580,049 | $210,047,343 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $305,058,100 | 2,373,993 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $279,348,624 | 2,322,293 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $262,936,848 | 2,497,975 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $252,304,658 | 3,006,132 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $250,416,089 | 3,163,417 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $233,961,773 | 2,606,526 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $264,359,246 | 2,657,411 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $363,809,673 | 3,203,678 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $409,382,706 | 3,306,807 | Shares | Defined | 2024-07-23 | |
| 2024-03-31 | $386,452,916 | 2,928,783 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $320,958,259 | 2,944,031 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $324,169,783 | 3,148,808 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $353,189,866 | 3,060,836 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $352,811,581 | 3,316,210 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $401,391,359 | 3,617,768 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $348,624,697 | 4,048,127 | Shares | Defined | 2022-12-01 | |
| 2022-06-30 | $373,762,446 | 4,099,621 | Shares | Defined | 2022-12-01 | |
| 2022-03-31 | $311,328,386 | 3,794,374 | Shares | Defined | 2022-12-01 | |
| 2021-12-31 | $392,656,686 | 5,123,391 | Shares | Defined | 2022-12-01 | |
| 2021-09-30 | $325,381,852 | 4,332,071 | Shares | Defined | 2022-12-01 | |
| 2021-06-30 | $345,038,892 | 4,436,658 | Shares | Defined | 2022-12-01 | |
| 2021-03-31 | $346,998,157 | 4,501,206 | Shares | Defined | 2022-12-01 | |
| 2020-12-31 | $342,129,982 | 4,182,520 | Shares | Defined | 2022-12-01 | |
| 2020-09-30 | $292,078,034 | 3,521,132 | Shares | Defined | 2021-01-19 | |
| 2020-06-30 | $266,245,527 | 3,442,977 | Shares | Defined | 2021-01-19 | |
| 2020-03-31 | $311,829,688 | 4,052,896 | Shares | Defined | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||